Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026
Enlivex Ltd. (Nasdaq: ENLV) announced a 1-for-15 reverse stock split effective July 9, 2026. Authorized shares fall from 2,375,000,000 to 158,333,334 and par value rises from NIS 0.40 to NIS 6.00. Issued shares drop from 252,480,222 to ~16,832,015, with proportional warrant/option adjustments. Shares continue trading under ENLV.
How this was made
The 30-second read
Why it matters
The corporate action will mechanically adjust the stock price and per-share figures; it may also influence investor sentiment and trading liquidity around the effective date, but the release does not provide new clinical or financial catalysts.
Market read
This is a time-specific corporate action for ENLV with clear mechanics (ratio, effective date, share-count changes) that can drive short-term trading behavior.
What to watch
Traders should watch for warrant/option exercise price and share-issuance adjustments, plus any rounding effects that could slightly alter outstanding share counts and near-term float/liquidity.
Background
Enlivex (ENLV) is executing a 1-for-15 reverse stock split, reducing authorized and issued shares and increasing par value, effective July 9, 2026.
Ticker impact
Enlivex announced a 1-for-15 reverse split effective July 9, 2026, with split-adjusted trading on Nasdaq under ENLV.
Likely short-term volatility around July 9 due to mechanical price adjustment and potential sentiment/compliance read-through; direction uncertain from the release alone.
The release provides exact split ratio and effective date but no new operating/financial guidance; impact is primarily mechanical/corporate-action driven.
Market effects
Limited direct read-through to the broader longevity/biotech sector; this is company-specific capital structure mechanics.
Minimal—Nasdaq-listed microcap corporate action with localized liquidity effects.
Low—no cross-border deal, regulator action, or sector-wide catalyst disclosed.
Counterpoint
A reverse split can be viewed as a liquidity/compliance step rather than a fundamental deterioration; price action may be muted if investors already priced the risk.
Key entities
- issuerEnlivex Ltd.
Nasdaq-listed company executing a 1-for-15 reverse stock split effective July 9, 2026.
- transfer_agentVStock Transfer, LLC
Transfer agent acting as exchange agent for the reverse split.
